PPARGC1A and pancreatic neoplasm: PPARGC1A was found to be elevated in CTCs from a variety of experimental models [78], and has been shown to play a role in oxidative phosphorylation in breast and pancreatic cancer cells, helping them meet their growing demand for energy as they proliferate rapidly [78,79].